Emcure’s Bold Move: Fully Acquires Zuventus to Power Next Pharma Leap

Emcure Pharmaceuticals has successfully acquired 4,095,180 equity shares of Zuventus Healthcare, representing 20.42% of its total issued and paid-up capital for an aggregate consideration of Rs. 7,249 million. This acquisition makes Zuventus a wholly owned subsidiary of Emcure, marking a key milestone in the company’s domestic consolidation strategy.

 

Key Highlights:

Source: Company Disclosure to the Stock Exchanges